The Influence of the Protozoan Giardia lamblia on the Modulation of the Immune System and Alterations in Host Glucose and Lipid Metabolism.
Sylwia KlimczakKacper PackiAlicja RudekSylwia WenclewskaMarcin KurowskiDaniela KurczabińskaAgnieszka SliwinskaPublished in: International journal of molecular sciences (2024)
Giardia lamblia , the cause of giardiasis, significantly impacts patients with metabolic disorders related to insulin resistance (IR). Both giardiasis and metabolic disorders share elements such as chronic inflammation and intestinal dysbiosis, which substantially affect the metabolic and cytokine profiles of patients. This review discusses the mechanisms of virulence of G. lamblia , its influence on the immune system, and its association with metabolic disorders. The review aims to show how G. lamblia invasion acts on the immune system and the glucose and lipid metabolism. Key findings reveal that G. lamblia infection, by disrupting intestinal permeability, alters microbiota composition and immune responses, potentially impairing metabolic status. Future research should focus on elucidating the specific mechanisms by which G. lamblia influences the metabolism, exploring the long-term consequences of chronic infection, and developing targeted therapeutic strategies that include both parasitic and metabolic aspects. These insights underscore the need for a multidisciplinary approach to the treatment of giardiasis in patients with metabolic disorders.
Keyphrases
- insulin resistance
- end stage renal disease
- oxidative stress
- escherichia coli
- ejection fraction
- endothelial cells
- type diabetes
- chronic kidney disease
- blood pressure
- drug delivery
- high fat diet
- toll like receptor
- cancer therapy
- prognostic factors
- current status
- polycystic ovary syndrome
- drug induced
- biofilm formation
- quality improvement
- antimicrobial resistance
- dna methylation
- candida albicans